We’re planning the official launch of eDrugSearch.com next month, but that doesn’t mean you can’t become a member of the site today. We encourage you to sign up now to begin saving on prescription medications by searching from our more than 20,000 listings. All drug listings are from licensed online pharmacies that meet [...]

[Read more →]

Rite Aid Corp. — the third-biggest drugstore chain, which recently agreed to buy the Eckerd and Brooks chains as well — has seen its profits rise of late after its introduction of generic versions of drugs such as Zoloft.
Why? Because generic medications carry a higher profit margin for the big chains than brand-name drugs.
Let me [...]

[Read more →]

From Reuters:
Pfizer Inc. is bracing for cheap competition to its biggest-selling product, the cholesterol drug Lipitor, a further worry for investors already reeling from the failure of its most important experimental medication. Last week, a raft of generic drugmakers announced that they had received U.S. approval to sell cheap versions of Merck & Co.’s rival [...]

[Read more →]

From the St. Petersburg Times:
Susan Schaefer LaRose quit her sales job in May after 18 years with pharmaceutical giant Eli Lilly and Co., frustrated by long work weeks that frequently encroached on weekends and vacations. And then she sued. Her lawsuit, part of a series of class-action claims filed last month against nine major [...]

[Read more →]

One of the advantages of ordering medications through eDrugSearch.com is that you don’t have to deal with less-than-discreet employees at the local pharmacy. This poor schlub illustrates (although he’s actually at a doctor’s office in this case) …

[Read more →]

From the Indianapolis Colts Web site:
In 2006, Kristie was chosen to represent the Indianapolis Colts in the first ever NFL Cheerleader Playoffs television show … Kristie works at Eli Lilly and Company as an Associate Analytical Chemist. She … would like to shift her career path towards Pharmaceutical Sales at Lilly in the near [...]

[Read more →]

From Time Magazine:
Too Little Bang for the Buck in Drug Research?
A new government report spotlights an apparent lack of productivity in Big Pharma’s pipeline
Whenever critics complain about the high cost of prescription drugs, the pharmaceutical industry’s standard defense is that companies have to plow so much money into researching innovative new medicines. But a recently [...]

[Read more →]

Drug companies appear to be cutting back on cost of sales through a combination of layoffs and hiring younger sales reps.
A recent article on Forbes.com stated,
Cost cutting is likely to continue for large-cap pharmaceutical companies in 2007 and cuts in international sales forces could be a further source of savings, according to Banc [...]

[Read more →]

According to Peter Rost:
Newspapers were filled with information about Dr. McKinnell’s $82 million pension package this spring. Shareholders were upset that Dr. McKinnell would receive this amount considering that Pfizer’s stock had lost 37% of its value during Dr. McKinnell’s tenure. Dr. McKinnell claimed that this wasn’t his fault. He said that the stock had [...]

[Read more →]

Bristol-Myers Squibb has reached a $499 million settlement to dismiss federal investigations into questionable drug pricing and marketing tactics.
According to the Pittsburgh Tribune-Review:
The company entered an agreement in principle with the Justice Department and the U.S. Attorney in Massachusetts to pay the settlement and avoid civil and criminal charges. Bristol-Myers will also enter a [...]

[Read more →]